Literature DB >> 1286494

Assessing health-related quality of life: application to drug therapy.

S J Coons1, R M Kaplan.   

Abstract

There is growing awareness among the principal stakeholders in health care that health outcomes data should be used in the evaluation of medical care interventions. Health-related quality of life is a patient-reported health outcome that is gaining increasing attention. In fact, in certain diseases, quality of life may be the most important health outcome to consider in assessing treatment efficacy. Quality of life is a construct commonly viewed as having several dimensions or domains. Although the terminology may differ depending on the author, the basic dimensions of health-related quality of life are physical status and functioning, emotional/psychological status, social functioning, and disease- or treatment-related symptomatology. There are a number of methodologic issues in the measurement of quality of life that must be carefully considered when designing a study or evaluating existing research. These issues include general or disease-specific measures, index or profile outcome measures, dimensions measured, relative importance of dimensions, reliability of the measure, and validity of the measure. This paper provides a brief overview of health-related quality of life and its measurement in the context of drug therapy.

Entities:  

Mesh:

Year:  1992        PMID: 1286494

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  6 in total

Review 1.  Patient-reported outcomes as end points and outcome indicators in solid tumours.

Authors:  Angeles A Secord; Robert L Coleman; Laura J Havrilesky; Amy P Abernethy; Gregory P Samsa; David Cella
Journal:  Nat Rev Clin Oncol       Date:  2015-03-10       Impact factor: 66.675

2.  Translating safety, efficacy and compliance into economic value for controlled release dosage forms.

Authors:  M P Cramer; S R Saks
Journal:  Pharmacoeconomics       Date:  1994-06       Impact factor: 4.981

3.  The effects of psychiatric disorders and symptoms on quality of life in patients with type I and type II diabetes mellitus.

Authors:  A M Jacobson; M de Groot; J A Samson
Journal:  Qual Life Res       Date:  1997-01       Impact factor: 4.147

4.  Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: An ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study.

Authors:  N T Phippen; A A Secord; S Wolf; G Samsa; B Davidson; A P Abernethy; D Cella; L J Havrilesky; R A Burger; B J Monk; C A Leath
Journal:  Gynecol Oncol       Date:  2017-07-23       Impact factor: 5.482

5.  Development and validation of 11 symptom indexes to evaluate response to chemotherapy for advanced cancer.

Authors:  David Cella; Sarah K Rosenbloom; Jennifer L Beaumont; Susan E Yount; Diane Paul; Debra Hampton; Amy P Abernethy; Paul B Jacobsen; Karen Syrjala; Jamie H Von Roenn
Journal:  J Natl Compr Canc Netw       Date:  2011-03       Impact factor: 11.908

6.  Brief assessment of priority symptoms in hormone refractory prostate cancer: the FACT Advanced Prostate Symptom Index (FAPSI).

Authors:  Susan Yount; David Cella; Donald Banik; Talat Ashraf; Daniel Shevrin
Journal:  Health Qual Life Outcomes       Date:  2003-11-21       Impact factor: 3.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.